YVONNE JONES: Open Payments
NPI 1518507920 · MILLSBORO, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$339 in 14 payments from 12 companies in 2025. Trend: 2023 $223 · 2024 $225 · 2025 $339
Food & beverage: $339
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $85 |
| Corcept Therapeutics | 1 | $40 |
| Lilly USA, LLC | 1 | $32 |
| Boston Scientific Corporation | 1 | $30 |
| BETA BIONICS, INC. | 1 | $30 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $23 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| Insulet Corporation | 1 | $19 |
| Sequel Med Tech, LLC | 1 | $17 |
| Amgen Inc. | 1 | $15 |
Products named: Korlym, Ozempic, MOUNJARO, WaveWriter Alpha Prime 16, iLet Bionic Pancreas, Rybelsus, Kerendia, Wegovy.
Industry payments across DE — which companies pay providers there.
